{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:53:46Z","timestamp":1791334426842,"version":"4.3.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","award":["IMSS R-2023-785-008"],"award-info":[{"award-number":["IMSS R-2023-785-008"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellimm.2026.105153","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:23:03Z","timestamp":1788733383000},"page":"105153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of changes in the phenotypic profile and frequencies of peripheral blood myeloid-derived suppressor cells in patients with endometrial cancer before and after surgical treatment"],"prefix":"10.1016","volume":"428-429","author":[{"given":"Eligio","family":"Estrada-Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Solorzano-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Villegas-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Azucena","family":"Palafox-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 de Jes\u00fas","family":"Guerrero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Sofia","family":"Guitron-Avi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Ra\u00fal","family":"V\u00e1zquez-Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Naomi","family":"Guevara-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo C.","family":"Ortiz-Lazareno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2026.105153_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2026.105153_bb0010","article-title":"Advances in the management of endometrial cancer","volume":"388","author":"Corr","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.cellimm.2026.105153_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413275","article-title":"Cancer Immunoediting and beyond in 2021","volume":"22","author":"Borroni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2026.105153_bb0025","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.18632\/oncotarget.12278","article-title":"On the origin of myeloid-derived suppressor cells","volume":"8","author":"Millrud","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2026.105153_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellimm.2026.105153_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jss.2019.08.022","article-title":"Surgical stress increases circulating low-density neutrophils which may promote tumor recurrence","volume":"246","author":"Kumagai","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cellimm.2026.105153_bb0040","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.18632\/oncotarget.14991","article-title":"Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2026.105153_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2026.105153_bb0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0055","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2026.105153_bb0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellimm.2026.105153_bb0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/hepr.12831","article-title":"Circulating CD14(+) HLA-DR(\u2212\/low) myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery","volume":"47","author":"Gao","year":"2017","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cellimm.2026.105153_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3892\/or.2012.1812","article-title":"Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer","volume":"28","author":"Ohki","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellimm.2026.105153_bb0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1164\/rccm.201708-1707OC","article-title":"Circulating and tumor myeloid-derived suppressor cells in Resectable non-small cell lung Cancer","volume":"198","author":"Yamauchi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellimm.2026.105153_bb0080","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1038\/s41598-022-13855-1","article-title":"Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer","volume":"12","author":"Liang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2026.105153_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirpalpha on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.cellimm.2026.105153_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104258","article-title":"Molecular cargo in myeloid-derived suppressor cells and their exosomes","volume":"359","author":"Fenselau","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41419-025-07779-7","article-title":"SIRPalpha blockade therapy potentiates immunotherapy by inhibiting PD-L1(+) myeloid cells in hepatocellular carcinoma","volume":"16","author":"Huang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2026.105153_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1564505","article-title":"Tim-3\/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients","volume":"8","author":"Limagne","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellimm.2026.105153_bb0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","article-title":"Emerging Tim-3 functions in antimicrobial and tumor immunity","volume":"32","author":"Sakuishi","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109546","article-title":"Disruption of CD47-SIRPalpha signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells","volume":"27","author":"Zimarino","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.cellimm.2026.105153_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRPalpha signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2026.105153_bb0120","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1074\/jbc.M109720200","article-title":"Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2026.105153_bb0125","doi-asserted-by":"crossref","first-page":"18342","DOI":"10.1073\/pnas.1106550108","article-title":"CD47-signal regulatory protein-alpha (SIRPalpha) interactions form a barrier for antibody-mediated tumor cell destruction","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellimm.2026.105153_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2026.105153_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellimm.2026.105153_bb0140","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1038\/s41598-020-64841-4","article-title":"Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic myeloid-derived suppressor cells","volume":"10","author":"Ren","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2026.105153_bb0145","article-title":"Myeloid diagnostic and prognostic markers of immune suppression in the blood of glioma patients","volume":"12","author":"Del Bianco","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00004836-199401000-00019","article-title":"Serum arginase level in patients with gastric cancer","volume":"18","author":"Wu","year":"1994","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12957-021-02426-9","article-title":"The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection","volume":"19","author":"Qiang","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0160","article-title":"VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2026.105153_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112840","article-title":"Arginase: an emerging and promising therapeutic target for cancer treatment","volume":"149","author":"Niu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2026.105153_bb0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cyto.a.24501","article-title":"PeacoQC: peak-based selection of high quality cytometry data","volume":"101","author":"Emmaneel","year":"2022","journal-title":"Cytometry A"},{"key":"10.1016\/j.cellimm.2026.105153_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030483","article-title":"Machine learning methods in clinical flow cytometry","volume":"17","author":"Spies","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellimm.2026.105153_bb0185","unstructured":"Cluster Explorer, FlowJo Documentation (n.d.). https:\/\/docs.flowjo.com\/flowjo\/advanced-features\/clusterexplorer\/ (accessed December 15, 2025)."},{"key":"10.1016\/j.cellimm.2026.105153_bb0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cyto.b.21588","article-title":"PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data","volume":"94","author":"DiGiuseppe","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.cellimm.2026.105153_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2026.105153_bb0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64653","article-title":"Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy","volume":"10","author":"Barone","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.cellimm.2026.105153_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.4149","article-title":"Characterizing cell subsets using marker enrichment modeling","volume":"14","author":"Diggins","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellimm.2026.105153_bb0210","first-page":"10 21 11","article-title":"Generating quantitative cell identity labels with marker enrichment modeling (MEM)","volume":"83","author":"Diggins","year":"2018","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.cellimm.2026.105153_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001223","article-title":"Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation","volume":"8","author":"Cassetta","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cellimm.2026.105153_bb0220","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2026.105153_bb0225","article-title":"Dietary factors and endometrial cancer risk: a Mendelian randomization study","volume":"15","author":"Wang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.cellimm.2026.105153_bb0230","doi-asserted-by":"crossref","unstructured":"H.E. Dinkelspiel, J.D. Wright, S.N. Lewin, T.J. Herzog, Contemporary clinical management of endometrial cancer, Obstet. Gynecol. Int. (2013) 2013 ;1-11:583891.","DOI":"10.1155\/2013\/583891"},{"key":"10.1016\/j.cellimm.2026.105153_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.cellimm.2026.105153_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0245","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0250","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.18632\/oncotarget.4772","article-title":"A phase 1\/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer","volume":"6","author":"Dijkgraaf","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2026.105153_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104274","article-title":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: a pilot study","volume":"360","author":"Gebhardt","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-018-2288-8","article-title":"The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial","volume":"68","author":"Huijts","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2026.105153_bb0265","doi-asserted-by":"crossref","first-page":"1148692","DOI":"10.3389\/fimmu.2023.1148692","article-title":"The current understanding of the immune landscape relative to radiotherapy across tumor types","volume":"14","author":"Iliadi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9124096","article-title":"Surgical stress promotes tumor progression: a focus on the impact of the immune response","volume":"9","author":"Onuma","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cellimm.2026.105153_bb0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2019.00215","article-title":"Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: novel strategies for preventing the tumor-protective effects of radiotherapy","volume":"9","author":"Ostrand-Rosenberg","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2018.03.007","article-title":"Myeloid derived-suppressor cells: their role in cancer and obesity","volume":"51","author":"Ostrand-Rosenberg","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/nu11123012","article-title":"Increased adiposity enhances the accumulation of MDSCs in the tumor microenvironment and adipose tissue of pancreatic tumor-bearing mice and in immune organs of tumor-free hosts","volume":"11","author":"Turbitt","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.cellimm.2026.105153_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055818","article-title":"Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1\/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia","volume":"8","author":"Christiansson","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cellimm.2026.105153_bb0295","doi-asserted-by":"crossref","first-page":"39296","DOI":"10.1038\/srep39296","article-title":"PD-L1(+)MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment","volume":"6","author":"Iwata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2026.105153_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100825","article-title":"Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1\/PD-1 axis","volume":"13","author":"Sun","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41419-024-06834-z","article-title":"Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2026.105153_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106929","article-title":"Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation","volume":"88","author":"Yin","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0315","doi-asserted-by":"crossref","first-page":"1332205","DOI":"10.3389\/fcell.2023.1332205","article-title":"Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0320","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jcmm.14825","article-title":"CD8(+) T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3\/Gal-9 pathway","volume":"24","author":"Tao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellimm.2026.105153_bb0325","doi-asserted-by":"crossref","first-page":"eadg3736","DOI":"10.1126\/sciadv.adg3736","article-title":"Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy","volume":"9","author":"Sarkar","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellimm.2026.105153_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350375","article-title":"SIRPalpha: a key player in innate immunity","volume":"53","author":"Feng","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2025.111254","article-title":"Exploring NK cell dynamics and the CD47-SIRPalpha axis in colon cancer","volume":"86","author":"Yilmaz","year":"2025","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0340","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in Cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0345","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","article-title":"Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity","volume":"105","author":"Munder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2026.105153_bb0350","article-title":"Inhibition of arginase 1 liberates potent T cell Immunostimulatory activity of human neutrophil granulocytes","volume":"11","author":"Vonwirth","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105153_bb0355","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.201701-0046ED","article-title":"Myeloid-derived suppressor cells in Sepsis","volume":"196","author":"van der Poll","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874926000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874926000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:44:29Z","timestamp":1791333869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874926000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":70,"alternative-id":["S0008874926000948"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105153","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of changes in the phenotypic profile and frequencies of peripheral blood myeloid-derived suppressor cells in patients with endometrial cancer before and after surgical treatment","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105153"}}